New ozagrel sodium compound and medicinal composition thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 周晓东
- Publication Date
- 2012-08-01
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The present invention relates to a new ozagrel sodium compound and its pharmaceutical composition. Background technique
[0002] Cardiovascular and cerebrovascular diseases are diseases that seriously affect human life and health, and are also one of the diseases with high morbidity and mortality. Among them, cerebrovascular diseases occupy an important position in cardiovascular and cerebrovascular diseases. According to reports, there are as many as 1.5 million first-time cerebrovascular diseases in my country every year, and it has become the second largest disease that seriously affects the health of our people.
[0003] Sodium ozagrel is a thromboxane synthase inhibitor, which can inhibit the generation of TXA2, has anti-platelet aggregation and blood vessel expansion effects, can inhibit cerebral thrombosis and cerebral vasospasm, and improve movement disorders in the acute stage of cerebral thrombosis. Clinically, it is widely used in the treat...